Please assess the completion status of the following clinical trial:

Trial Title: The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Korean~* Type 2 diabetes mellitus~* No prior history of diabetic ketoacidosis~* HbA1c between 7.5-10.0%~Exclusion Criteria:~* Type 1 diabetes mellitus~* Gestational diabetes mellitus~* Secondary diabetes mellitus~* Severe hyperglycemia with symptoms~* Severe chronic diabetic complications (PDR,s-Cr\>1.3mg/dL)

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).